SLC5A2 and intestinal obstruction: A study using 2 data repositories from the United Kingdom included data from 25 617 subjects treated with GLP-1RAs and compared the rate of bowel obstruction with 67 261 subjects treated with sodium-glucose cotransporter-2 (SGLT-2) inhibitors using propensity-score matching (91).